Correction (DOI:10.1016/j.jacc.2005.10.020);ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on performance measures (Writing Committee to develop performance measures on ST-elevation and non-ST-elevation myocardial infarction)

Journal of the American College of Cardiology

Volumn 47, Issue 1, 2006, Pages 236-265

  Krumholz, Harlan M ^a   Anderson, Jeffrey L ^a   Brooks, Neil H ^a   Fesmire, Francis M ^a   Lambrew, Costas T ^a   Landrum, Mary Beth ^a   Weaver, W Douglas ^a   Whyte, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; FIBRINOLYTIC THERAPY; HEALTH CARE ORGANIZATION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; JOB PERFORMANCE; MANAGEMENT; MEDICAL ASSESSMENT; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SERVICE; MEDICAL SOCIETY; MEDICARE; ORGANIZATION; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SMOKING CESSATION PROGRAM; ST SEGMENT ELEVATION; TASK PERFORMANCE;

EID: 29344450425     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.04.011     Document Type: Erratum

References (16)

1. J.A. Spertus, K.A. Eagle, H.M. Krumholz, K.R. Mitchell, S.L. Normand American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care J Am Coll Cardiol 45 2005 1147 1156
2. American Heart Association Heart Disease and Stroke Statistics - 2003 update 2002 American Heart Association Dallas, TX
3. E. Braunwald Acute myocardial infarction - the value of being prepared N Engl J Med 334 1996 51 52
4. T.J. Ryan, E.M. Antman, N.H. Brooks 1999 update: ACC/AHA guideline for the management of patients with acute myocardial infarction. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 34 1999 890 911
5. E. Braunwald, E.M. Antman, J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
6. E.M. Antman, D.T. Anbe, P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction J Am Coll Cardiol 44 2004 671 719
7. C.P. Cannon, A. Battler, R.G. Brindis American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) J Am Coll Cardiol 38 2001 2114 2130
8. S.C. Smith Jr., S.N. Blair, R.O. Bonow AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 104 2001 1577 1579
9. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
10. J.D. Rutherford, M.A. Pfeffer, L.A. Moye SAVE Investigators Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial Circulation 90 1994 1731 1738
11. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4 a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
12. F. Pizzetti, F.M. Turazza, M.G. Franzosi Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction the GISSI-3 data Heart 86 2001 527 532
13. E. Ambrosioni, C. Borghi, B. Magnani The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction N Engl J Med 332 1995 80 85
14. C. Torp-Pedersen, L. Kober Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation Lancet 354 1999 9 12
15. K. Dickstein, J. Kjekshus Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan Lancet 360 2002 752 760
16. M.A. Pfeffer, J.J. McMurray, E.J. Velazquez Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906